FilingSEC EDGAR8-K
Altimmune Draws $10 Million Under Existing Loan Agreement
· SEC accepted
StageN/A
Filing content
Altimmune drew $10 million from its existing loan agreement following the achievement of clinical and financial milestones.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…